Related Experiment Videos
Platelet alpha2-adrenoreceptors in obsessive-compulsive disorder
Donatella Marazziti1, Stefano Baroni, Irene Masala
1Dipartimento di Psichiatria, Neurobiologia, Farmacologia e Biotecnologie, Università di Pisa, Pisa, Italy. dmarazzi@psico.med.unipi.it
Neuropsychobiology
|February 26, 2004
Summary
Researchers found no significant differences in platelet alpha(2)-adrenoreceptors between obsessive-compulsive disorder (OCD) patients and controls. This suggests the norepinephrine system
Area of Science:
- Neuroscience
- Psychiatry
- Pharmacology
Background:
- Obsessive-compulsive disorder (OCD) requires novel therapeutic targets.
- The norepinephrine system's role in OCD is not fully understood.
- Platelet alpha(2)-adrenoreceptors are investigated as a potential biomarker.
Purpose of the Study:
- To investigate the involvement of the norepinephrine system via platelet alpha(2)-adrenoreceptors in OCD.
- To compare alpha(2)-adrenoreceptor density in OCD patients versus healthy controls.
Main Methods:
- Recruited 20 OCD patients and age/sex-matched healthy controls.
- Prepared platelet membranes using standard protocols.
- Measured alpha(2)-adrenoreceptors via [(3)H]rauwolscine binding.
Main Results:
- No significant differences in [(3)H]rauwolscine binding parameters were observed between OCD patients and controls.
- Platelet alpha(2)-adrenoreceptor levels did not differ between the groups.
- A trend towards higher alpha(2)-adrenoreceptor density was noted in OCD patients with motor tics.
Conclusions:
- The role of alpha(2)-adrenoreceptors, as assessed by the platelet model, appears limited in OCD.
- Norepinephrine system involvement in OCD may be symptom-specific, potentially related to motor control.
- Further research is needed to clarify the precise role of alpha(2)-adrenoreceptors in OCD pathophysiology.